Are you concerned about drug safety?
The US FDA MedWatch safety alert system aims to rapidly inform drug providers and consumers about updated safety information on the human healthcare products - drugs, both Rx and OTC, medical devices and diagnostics, biologics, and dietary supplements - that FDA monitors for safety following their approval. It is an important system.
The FDA intends that the information from MedWatch be concise, science-based, unbiased and clinically useful information that will help both provider and patient as they consider treatment choices. To assist both healthcare professionals and the healthcare consuming public to better understand the challenges of post-marketing drug and device surveillance and what FDA offers to address that challenge, the MedWatch Medical Director, Dr Norman S Marks, recently announce the availability of a web-based self-learning tutorial, "FDA MedWatch and Patient Safety", available at http://www.connectlive.com/events/fdamedwatch/.